Feedback / Questions
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
https://www.pharmiweb.com/press-release/2023-12-07/health-canada-approves-fyb201ranopto-ranibizumab-a-biosimilar-to-lucentis
Dec 7, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next